Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Recombinant Human Interleukin-7 (CYT107) Enhances CD4 and CD8 T Cell Recovery Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant In Patients with Myeloid Malignancies

Blood (2010) 116 (21): 674.

https://doi.org/10.1182/blood.V116.21.674.674

Published: 2010

Journal Articles

Pertussis Response to Tdap (8 mcg/dose of the Pertussis Toxoid (PT) In Recipients of Allogeneic Hematopoietic Stem Cell Transplants (Allo HSCT).

Esperanza Papadopoulos, MD, Christine Scurra Iovino, APRN-BC, FNP-C, Molly Knowles, BA, Juliet Barker, MBBS, (Hons), FRACP, Andromachi Scaradavou, MD, Nancy A Kernan, MD, Trudy N Small, M.D

Blood (2010) 116 (21): 1282.

https://doi.org/10.1182/blood.V116.21.1282.1282

Published: 2010

Journal Articles

Vaccine Response In Recipients of HLA Mismatched Unrelated Double Unit Cord Blood Transplantation (CBT).

Trudy N Small, M.D, Christine Scura Iovino, APRN-BC, FNP-C, Michelle Abboud, RN, BSN, OCN, Marissa Lubin, BA, Esperanza Papadopoulos, MD, Andromachi Scaradavou, MD, Juliet N Barker, MBBS, (Hons), FRACP

Blood (2010) 116 (21): 1247.

https://doi.org/10.1182/blood.V116.21.1247.1247

Published: 2010

Journal Articles

Adoptive Immune Cell Therapy Using Third Party T-Cell Donors In the Treatment of EBV Related Diseases In Immunodeficient Recipients

Susan Prockop, MD, Ekaterina Doubrovina, MD, PhD, Farid Boulad, MD, Nancy A Kernan, MD, Rachel Kobos, MD, Andromachi Scaradavou, Trudy N Small, M.D, Ramzi Khalaf, Juliet Barker, MBBS, (Hons), FRACP, Guenther Koehne, MD, Esperanza Papadopoulos, MD, James W. Young, MD, Richard J. O'Reilly, MD

Blood (2010) 116 (21): 487.

https://doi.org/10.1182/blood.V116.21.487.487

Published: 2010

Journal Articles

T-Cell Depletion Is An Alternative Approach for Patients >/= 55 Years Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Diseases

Erica Petrlik, MD, Hugo Castro-Malaspina, MD, Farid Boulad, MD, Esperanza Papadopoulos, MD, Ann A. Jakubowski, MD, PhD

Blood (2010) 116 (21): 1338.

https://doi.org/10.1182/blood.V116.21.1338.1338

Published: 2010

Journal Articles

A Phase I-II Dose Escalation Trial of Clofarabine Plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia

Farid Boulad, MD, Nancy A Kernan, MD, Susan E Prockop, MD, Andromachi Scaradavou, MD, Trudy N Small, M.D, Elizabeth G Klein, Juliet Barker, MBBS, (Hons), FRACP, Ann A. Jakubowski, MD, PhD, Guenther Koehne, MD, Esperanza Papadopoulos, MD, Miguel-Angel Perales, MD, James W. Young, MD, Richard J. O'Reilly, MD

Blood (2010) 116 (21): 2354.

https://doi.org/10.1182/blood.V116.21.2354.2354

Published: 2010

Journal Articles

Early Immune Recovery Predicts Overall and Disease-Free Survival After Allogeneic Hematopoietic Stem Cell Transplantation.

Jenna D. Goldberg, MD, Junting Zheng, MA, Juliet Barker, MBBS, Farid Boulad, MD, H.R. Castro-Malaspina, MD, Katharine C Hsu, MD, PhD, Ann Jakubowski, MD, PhD, Nancy Kernan, MD, Richard J O'Reilly,, MD, Esperanza Papadopoulos, MD, Susan Prockop, MD, Andromachi Scaradavou, MD, Marcel van den Brink, MD, PhD, James Young, MD, Glenn Heller, PhD, Miguel-Angel Perales, MD

Blood (2009) 114 (22): 2222.

https://doi.org/10.1182/blood.V114.22.2222.2222

Published: 2009

Journal Articles

Phase II Trial of a Chemotherapy-Only Regimen of Busulfan, Melphalan, Fludarabine and R-ATG Followed by Allogeneic T-Cell Depleted (TCD) Hematopoietic Stem Cell Transplants (HSCT) for the Treatment of Myeloid Malignancies.

Farid Boulad, MD, Ann Jakubowski, MD, Esperanza Papadopoulos, MD, Katharine C. Hsu, MD, Miguel Angel Perales, MD, Marcel van den Brink, MD, James W. Young, MD, Michelle Chiu, Nancy A. Kernan, MD, Susan E. Prockop, MD, Andromachi Scaradavou, MD, Trudy N. Small, MD, Hugo Castro-Malaspina, MD, Richard J. O’Reilly, MD

Blood (2007) 110 (11): 2991.

https://doi.org/10.1182/blood.V110.11.2991.2991

Published: 2007

NARROW

Recombinant Human Interleukin-7 (CYT107) Enhances CD4 and CD8 T Cell Recovery Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant In Patients with Myeloid Malignancies

Pertussis Response to Tdap (8 mcg/dose of the Pertussis Toxoid (PT) In Recipients of Allogeneic Hematopoietic Stem Cell Transplants (Allo HSCT).

Vaccine Response In Recipients of HLA Mismatched Unrelated Double Unit Cord Blood Transplantation (CBT).

Adoptive Immune Cell Therapy Using Third Party T-Cell Donors In the Treatment of EBV Related Diseases In Immunodeficient Recipients

T-Cell Depletion Is An Alternative Approach for Patients >/= 55 Years Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Diseases

A Phase I-II Dose Escalation Trial of Clofarabine Plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia

Early Immune Recovery Predicts Overall and Disease-Free Survival After Allogeneic Hematopoietic Stem Cell Transplantation.

Phase II Trial of a Chemotherapy-Only Regimen of Busulfan, Melphalan, Fludarabine and R-ATG Followed by Allogeneic T-Cell Depleted (TCD) Hematopoietic Stem Cell Transplants (HSCT) for the Treatment of Myeloid Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only